About this trial
The purpose of this an open-label, randomized controlled trial study is to compare the effectiveness of electronic cigarettes (e-cigarettes/e-cigs) versus telehealth motivational counseling with combination nicotine replacement therapy (NRT) + telehealth counseling on combustible cigarettes smoking reduction among persons with opioid use disorder (OUD) in methadone and buprenorphine treatment programs (opioid use disorder treatment programs (OUDTP)). OUDTP patients are a population with exceptionally high combustible cigarettes smoking burden and yet limited success in achieving meaningful clinical outcomes in tobacco treatment. If effective, electronic cigarettes would provide an additional tool for tobacco harm reduction among this difficult-to-treat vulnerable population.
Eligibility criteria
Qualifiers
Currently smokes 5 or more CPD
Age ≥ 21 years
Has a diagnosis of Opioid Use Disorder
In OUDTP (buprenorphine or methadone) ≥ 12 weeks via self-report or EHR records
Disqualifiers
Does not speak English or Spanish
Are pregnant or breastfeeding
Not able to provide consent
Used tobacco products other than CC in the past 2 weeks (e.g., EC, cigarillo)
Trial design
Treatments tested in this trial
- Telehealth Motivational Counseling
- Nicotine Replacement Product
- National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC).
Treatment groups
Sponsors and collaborators
NYU Langone Health
Lead sponsor
National Institutes of Health (NIH)
Collaborator